ArticleEndocrine connections2025
Modified stress hyperglycemia ratio identifies the risk of early cardiovascular complications in patients with acute myocardial infarction.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between stress hyperglycemia ratio and in-hospital mortality in acute myocardial infarction: a dose-response meta-analysis.BMC cardiovascular disorders · 2026Pooled it
- Effect of stress-induced hyperglycaemia on clinical outcome in paitients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stress hyperglycemia ratio (SHR) has been associated with poor outcomes in patients with acute myocardial infarction (AMI). Modified SHR (mSHR) is defined as the highest SHR observed within the first 24 h of admission. However, the association between mSHR and early cardiovascular complications (ECC) following AMI is unclear. Methods: This multicenter observational study incorporated retrospective and prospective analyses across two independent cohorts. The discovery and validation cohorts each included consecutive AMI patients admitted to intensive care units. The blood glucose and hemoglobin A1c levels were used to calculate mSHR. The primary outcome was the occurrence of ECC during the hospital stay. Results: In the discovery cohort, ECC occurred in 322 (23.9%) of 1,349 patients, and mSHR was independently associated with ECC (adjusted odds ratio: 1.164; 95% confidence interval (CI): 1.124-1.206; P < 0.001). Machine learning approaches identified mSHR as the most important feature. In the validation cohort, 303 patients were divided into three groups according to mSHR tertiles. Modified Poisson regression analysis showed that patients with mSHR ≥ 1.202 (tertile 3) had a significantly higher risk of ECC compared to those in tertiles 1-2 (adjusted risk ratio: 2.337; 95% CI: 1.479-3.693; P < 0.001). The results of multivariate analysis were consistent before and after applying inverse probability of treatment weighting. Conclusion: In AMI patients, mSHR is an accurate risk-stratification tool for identifying ECC. It may provide exploratory evidence to optimize current glycemic control strategies and early discharge pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.